You are here

  • Home
  • Archive
  • Volume 18, Issue 2
  • Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550 mg/m2 in patients with recurrent ovarian and peritoneal cancer

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550 mg/m2 in patients with recurrent ovarian and peritoneal cancer

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 2019800
Apr 20191500
May 20192600
Jun 20191801
Jul 20192000
Aug 20193300
Sep 20192500
Oct 20193000
Nov 20192000
Dec 2019800
Jan 20202800
Feb 20203700
Mar 2020800
Apr 2020800
May 20201700
Jun 20201701
Jul 20204301
Aug 20202000
Sep 20201800
Oct 2020900
Nov 20201800
Dec 20201600
Jan 20212600
Feb 2021600
Mar 20211500
Apr 20211301
May 20212002
Jun 2021200
Jul 2021100
Aug 2021101
Sep 2021200
Oct 20212300
Nov 20212500
Dec 20213800
Jan 20222800
Feb 20223101
Mar 20221200
Apr 20222100
May 20223500
Jun 20225400
Jul 20223200
Aug 20225000
Sep 20225601
Oct 20225300
Nov 20224100
Dec 20224201
Jan 20233800
Feb 20237900
Mar 20235800
Apr 20232801
May 20231903
Jun 20232202
Jul 2023800
Aug 20234700
Sep 20232200
Oct 20235800
Nov 20235700
Dec 20236501
Jan 2024800
Feb 20244000
Mar 20244800
Apr 20246900
Total1735017